Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Cryvista

Drug XLH Metabolic Bone Disorder

NDC 69794-102-01

Open in the dashboard

General payments

$287,485

2,047 payments

Research payments

$0

0 payments

Through program year 2020, $287,485 in general payments and $0 in research payments were reported against Cryvista (XLH Metabolic Bone Disorder).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $287,485 2,047

Breakdown

Who paid General payments · program year 2020
  1. Ultragenyx Pharmaceutical Inc. $287,485 2,047 payments
Top recipients General payments · program year 2020
  1. Anthony Portale Pediatrics · San Francisco, CA $30,812 11% · 33 payments
  2. Eric Rush Clinical Genetics (M.D.) · Kansas City, MO $19,984 7% · 27 payments
  3. Gnanagurdasan Prakasam Pediatric Endocrinology · Sacramento, CA $18,120 6% · 27 payments
  4. John Mahan Pediatric Nephrology · Columbus, OH $12,325 4% · 9 payments
  5. Kathryn Dahir Endocrinology, Diabetes & Metabolism · Nashville, TN $12,104 4% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $62,092 22% · 293 practitioners
  2. Pediatric Endocrinology Pediatrics $55,754 19% · 69 practitioners
  3. Pediatrics $36,586 13% · 199 practitioners
  4. Pediatric Nephrology Pediatrics $33,581 12% · 26 practitioners
  5. Clinical Genetics (M.D.) Medical Genetics $31,176 11% · 9 practitioners

The top 5 of 68 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $70,073 24% · 48 recipients
  2. Missouri $28,549 10% · 39 recipients
  3. New York $27,480 10% · 110 recipients
  4. Connecticut $18,505 6% · 28 recipients
  5. Tennessee $18,243 6% · 54 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

2,047 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record